BFH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bread Financial Holdings Inc (BFH) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and recent share repurchase authorization indicate a solid growth trajectory. Despite the lack of Intellectia Proprietary Trading Signals, the technical indicators and options data suggest a favorable entry point for long-term investment.
The MACD is positive and expanding, indicating bullish momentum. The RSI is at 70.228, which is neutral but approaching overbought territory. The stock price is above the pivot point (74.558) and nearing resistance levels (R1: 78.045, R2: 80.2), suggesting upward momentum. Moving averages are converging, which could signal a potential breakout.
Analysts have upgraded price targets, with some projecting up to $92, citing improving earnings trends, solid capital returns, and a strengthened balance sheet.
The company reported significant YoY growth in net income (671.43%) and EPS (735.71%) in Q4
A $600 million increase in share repurchase authorization reflects management's confidence in the company's future performance.
Broader economic factors, such as increased tax refunds, are expected to boost consumer spending, benefiting Bread Financial.
Some analysts, such as Barclays and Morgan Stanley, maintain an Underweight rating, citing only modest growth in
The post-market price decline of -1.93% may indicate some short-term profit-taking or resistance near current levels.
No recent congress trading data or significant hedge fund activity to confirm institutional confidence.
In Q4 2025, Bread Financial demonstrated strong financial performance with revenue increasing by 1.46% YoY to $1.041 billion, net income surging 671.43% YoY to $54 million, and EPS growing 735.71% YoY to 1.17. Gross margin also improved by 4.37% YoY to 80.88%. These metrics reflect robust growth and operational efficiency.
Analyst sentiment is generally positive, with multiple upgrades and raised price targets. Evercore ISI upgraded the stock to Outperform with a price target of $90, while UBS initiated coverage with a Buy rating and a $92 price target. However, Barclays and Morgan Stanley maintain Underweight ratings, citing modest growth expectations for 2026.
